B2 IMPACT ASA: Grant of Share Options (LTIP)
The Board of Directors of B2 Impact ASA (the "Company”) has resolved to grant, in accordance with the authorisation from the Annual General Meeting on 23 May 2024, share options to the management of the Company.
The share options are granted under a long-term incentive program (“LTIP”) aimed to align the interests of the participating employees with those of the Company's shareholders. The total number of share options awarded under LTIP 2024 is 2,700,000.
Each option, when exercised, will give the right to acquire one share in the Company. The share options have a strike price of NOK 9.672, equal to the average volume weighted average price of the Company's shares on Oslo Stock Exchange over the 20 last trading days prior to the grant date.
Pursuant to the vesting schedule, 1/3 of the options will vest one, two and three years after the grant date. Options that have not been exercised will lapse four (4) years after the grant date.
The following Primary Insiders of the Company have been granted share options:
Trond Kristian Andreassen, Chief Executive Officer, has been granted 1,000,000 share options. Following the grant, he holds 1,000,000 share options in the Company.
André Adolfsen, Chief Financial Officer, has been granted 500,000 share options. Following the grant, he holds 1,540,000 share options in the Company.
Adam Parfiniewicz, Chief Operating Officer, has been granted 400,000 share options. Following the grant, he holds 1,580,000 share options in the Company.
Jeremi Bobowski, Chief Risk and Compliance Officer, has been granted 400,000 share options. Following the grant, he holds 1,340,000 share options in the Company.
Endre Solvin-Witzø, Chief Investment Officer, has been granted 400,000 share options. Following the grant, he holds 1,100,000 share options in the Company.
This information is subject to the disclosure requirements in article 19 of the Regulation EU 596/2014 (the EU Market Abuse Regulation) and section 5-12 of the Norwegian Securities Trading Act.